{"disease":{"id":"chronic-inflammatory-demyelinating-polyradiculoneuropathy","name":"chronic inflammatory demyelinating polyradiculoneuropathy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05363358","title":"A Safety Study of GAMMAGARD LIQUID (GGL) in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)","phase":"","overall_status":"COMPLETED","enrollment_count":6086,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT06325878","title":"Genetic Architecture of Chronic Inflammatory Demyelinating Polyradiculoneuropathy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":3500,"lead_sponsor_name":"Istituto Clinico Humanitas","has_results":false},{"nct_id":"NCT07333196","title":"Tongji NADs Cohort","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1550,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT07091630","title":"A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":160,"lead_sponsor_name":"argenx","has_results":false},{"nct_id":"NCT06290128","title":"A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":140,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT02549170","title":"A Study of HyQvia and Gammagard Liquid (Kiovig) in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":138,"lead_sponsor_name":"Baxalta now part of Shire","has_results":true},{"nct_id":"NCT01625182","title":"Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":106,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT04658472","title":"Proof-of-concept Study for SAR445088 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":98,"lead_sponsor_name":"Bioverativ, a Sanofi company","has_results":false},{"nct_id":"NCT06615622","title":"Our Study Aims to Determine if Nerve Alterations in Acute GBS and CIDP Detectable by Ultrasound Match Electrodiagnostic Findings and if This Method Aids Early Diagnosis, Predict Their Outcomes and Differentiate Between Axonal and Demyelinating Subtypes.","phase":"","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT02955355","title":"Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDP","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":85,"lead_sponsor_name":"Baxalta now part of Shire","has_results":true},{"nct_id":"NCT02027701","title":"Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":82,"lead_sponsor_name":"CSL Behring","has_results":true},{"nct_id":"NCT06747351","title":"A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":59,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT04978623","title":"Role of High Frequency Ultrasound in Demyelinating Polyneuropathies","phase":"","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Centre Hospitalier Universitaire de Nice","has_results":false},{"nct_id":"NCT03460951","title":"Diffusion Tensor Imaging in Chronic Inflammatory Demyelinating Polyneuropathy (PIDC)","phase":"","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"University Hospital, Clermont-Ferrand","has_results":false},{"nct_id":"NCT03967899","title":"Study of Electrical Prognostic Factors of Response to Intravenous Immunoglobulin Treatment in Chronic Inflammatory Demyelinating Polyradiculoneuropathy","phase":"","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Fondation Hôpital Saint-Joseph","has_results":false},{"nct_id":"NCT04561557","title":"Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT06798012","title":"A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT03861481","title":"A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"UCB Biopharma S.P.R.L.","has_results":true},{"nct_id":"NCT06538064","title":"A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care","phase":"","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT07022197","title":"Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":27,"lead_sponsor_name":"Tianjin Medical University General Hospital","has_results":false},{"nct_id":"NCT05084053","title":"A Study of TAK-771 in Japanese Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":26,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT06485232","title":"Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":25,"lead_sponsor_name":"Xuanwu Hospital, Beijing","has_results":false},{"nct_id":"NCT03864185","title":"The Evaluation of Efficacy and Safety of Rituximab in Refractory CIDP Patients With IgG4 Autoantibodies","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Nagoya University","has_results":false},{"nct_id":"NCT02892890","title":"Exploratory Study of Predictive Markers of the Therapeutic Response in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy Treated With Intravenous Immunoglobulin","phase":"NA","overall_status":"COMPLETED","enrollment_count":23,"lead_sponsor_name":"Assistance Publique Hopitaux De Marseille","has_results":false},{"nct_id":"NCT04051944","title":"A Study to Assess Long-term Safety, Tolerability and Efficacy of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"UCB Biopharma SRL","has_results":true},{"nct_id":"NCT04356781","title":"Do IgG Level Variations in CIDP and MMN Patients Following Initial Intravenous IVIg Treatment Correlate With Ultimate Dosing","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Walton Centre NHS Foundation Trust","has_results":false},{"nct_id":"NCT04529291","title":"InertiaLocoGraphy as a Biomarker of Immunoglobulin Therapy Efficacy in Chronic Inflammatory Demyelinating Polyradiculoneuropathy","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Fondation Hôpital Saint-Joseph","has_results":false}],"total":27},"guidelines":[],"source":"Drug Landscape verified database"}